Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Boursi

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
JU Open Plus|February 19, 2026
Variations in Urinary Microbiota on a Short-Duration Space Mission to the International Space StationPaul H Chung, Ben Boursi, Harel Baris, et al.
Molecular and Clinical Oncology|April 11, 2019
Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?Ofer Margalit, Ronac Mamtani, Yaacov R Lawrence, et al.
The Israel Medical Association Journal : IMAJ|July 26, 2014
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factorsDana Livne-Segev, Maya Gottfried, Natalie Maimon, et al.
Eclinicalmedicine|January 19, 2026
Adolescent to adulthood weight trajectories and the risk of obesity-related cancers, overall and early-onset: a population-based cohort studyCole D Bendor, Aya Bardugo, Avishai M Tsur, et al.
Cancer Immunology Research|October 3, 2018
Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control StudyYael Eshet, Erez Nissim Baruch, Ronnie Shapira-Frommer, et al.
The Oncologist|January 31, 2019
Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal AdenocarcinomaOfer Margalit, Ronac Mamtani, Scott Kopetz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2021
The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyDan Assaf, Eyal Mor, Shachar Laks, et al.
Future Oncology (London, England)|December 17, 2019
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysisRavi B Parikh, Emily K Feld, Matthew D Galsky, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control studyAkram Saad, Jeffrey Goldstein, Ofer Margalit, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2022
Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical TrialLiat Hammer, David Hausner, Maoz Ben-Ayun, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
JU Open Plus|February 19, 2026
Variations in Urinary Microbiota on a Short-Duration Space Mission to the International Space StationPaul H Chung, Ben Boursi, Harel Baris, et al.
Molecular and Clinical Oncology|April 11, 2019
Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?Ofer Margalit, Ronac Mamtani, Yaacov R Lawrence, et al.
The Israel Medical Association Journal : IMAJ|July 26, 2014
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factorsDana Livne-Segev, Maya Gottfried, Natalie Maimon, et al.
Eclinicalmedicine|January 19, 2026
Adolescent to adulthood weight trajectories and the risk of obesity-related cancers, overall and early-onset: a population-based cohort studyCole D Bendor, Aya Bardugo, Avishai M Tsur, et al.
Cancer Immunology Research|October 3, 2018
Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control StudyYael Eshet, Erez Nissim Baruch, Ronnie Shapira-Frommer, et al.
The Oncologist|January 31, 2019
Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal AdenocarcinomaOfer Margalit, Ronac Mamtani, Scott Kopetz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2021
The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyDan Assaf, Eyal Mor, Shachar Laks, et al.
Future Oncology (London, England)|December 17, 2019
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysisRavi B Parikh, Emily K Feld, Matthew D Galsky, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control studyAkram Saad, Jeffrey Goldstein, Ofer Margalit, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2022
Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical TrialLiat Hammer, David Hausner, Maoz Ben-Ayun, et al.
Pageof 11